Phase Two Review

Phase Two Review is a formal in-depth assessment conducted by competition authorities to evaluate the potential anti-competitive effects of a merger that has failed to meet initial clearance criteria during the preliminary review, distinguishing it from the more superficial Phase One Review by involving comprehensive investigation and evidence gathering.

6

Publications

324

Citations

10

Authors

6

Institutions

Publications per year

2017–2026

1

Authors

10

  1. AB
    A. Barbeau

    Montreal Clinical Research Institute, Canada

    2 publications · 43 citations

    2

    h-index

  2. MH
    Martyn Hammersley

    The Open University, United Kingdom

    1 publications · 18 citations

    1

    h-index

  3. EM
    Elizabeth McDonough

    1 publications · 14 citations

    1

    h-index

  4. GD
    Galina Dimitrova

    University College London, United Kingdom

    1 publications · 95 citations

    1

    h-index

  5. NL
    N L Laird

    Harvard University, United States

    1 publications · 154 citations

    1

    h-index

1–5 of 10

Venues

  1. 2

    h-index

  2. Journal of Experimental Criminology

    1 publications · 95 citations

    1

    h-index

  3. Medical Care

    1 publications · 154 citations

    1

    h-index

  4. British Educational Research Journal

    BERJ · 1 publications · 18 citations

    1

    h-index

  5. Psychiatry Research

    1 publications · 13 citations

1–5